Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment for COVID-19-a cohort study from Northern Italy.
Guglielmetti L, Aschieri D, Kontsevaya I, Calabrese F, Donisi A, Faggi A, Ferrante P, Fronti E, Gerna L, Leoni MC, Paolillo F, Ratti G, Ruggieri A, Sacchini D, Scotti M, Valdatta C, Stabile M, Taliani G, Codeluppi M. Guglielmetti L, et al. Sci Rep. 2021 Oct 25;11(1):20964. doi: 10.1038/s41598-021-00243-4. Sci Rep. 2021. PMID: 34697322 Free PMC article.
COVID-19 in Italy: passing through bitter waters.
Guglielmetti L, Chiesi S. Guglielmetti L, et al. Eur Respir J. 2020 Jul 30;56(1):2001812. doi: 10.1183/13993003.01812-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32444413 Free PMC article.
Severe COVID-19 pneumonia in Piacenza, Italy - A cohort study of the first pandemic wave.
Guglielmetti L, Kontsevaya I, Leoni MC, Ferrante P, Fronti E, Gerna L, Valdatta C, Donisi A, Faggi A, Paolillo F, Ratti G, Ruggieri A, Scotti M, Sacchini D, Taliani G, Codeluppi M; COVID-Piacenza Group. Guglielmetti L, et al. J Infect Public Health. 2021 Feb;14(2):263-270. doi: 10.1016/j.jiph.2020.11.012. Epub 2020 Dec 9. J Infect Public Health. 2021. PMID: 33497876 Free PMC article.
Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure.
Taliani G, Follini E, Guglielmetti L, Bernuzzi P, Faggi A, Ferrante P, Fronti E, Gerna L, Leoni MC, Paolillo F, Ratti G, Ruggieri A, Valdatta C, Donisi A, Zangrandi A, Pochintesta L, Moroni C, Sacchini D, Vallisa D, Codeluppi M; COVID-Piacenza Group. Taliani G, et al. Among authors: guglielmetti l. Front Oncol. 2021 Jan 25;10:582901. doi: 10.3389/fonc.2020.582901. eCollection 2020. Front Oncol. 2021. PMID: 33585201 Free PMC article.
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
Domínguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gröschel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR Jr, Lange C; TBnet and RESIST-TB networks. Domínguez J, et al. Among authors: guglielmetti l. Lancet Infect Dis. 2023 Apr;23(4):e122-e137. doi: 10.1016/S1473-3099(22)00875-1. Epub 2023 Feb 28. Lancet Infect Dis. 2023. PMID: 36868253 Review.
Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.
Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Métivier N, Robert J; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Guglielmetti L, et al. Clin Infect Dis. 2015 Jan 15;60(2):188-94. doi: 10.1093/cid/ciu786. Epub 2014 Oct 15. Clin Infect Dis. 2015. PMID: 25320286
148 results